Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system.
about
Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosisThe outer surface proteins of Lyme disease borrelia spirochetes stimulate T cells to secrete interferon-gamma (IFN-gamma): diagnostic and pathogenic implicationsSerum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1aStage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple SclerosisNovel Insights and Therapeutics in Multiple SclerosisThe unfolded protein response in multiple sclerosisMultiple sclerosis-a quiet revolutionGut commensalism, cytokines, and central nervous system demyelinationMultiple sclerosis: the role of cytokines in pathogenesis and in therapiesInterferon Gamma: Influence on Neural Stem Cell Function in Neurodegenerative and Neuroinflammatory DiseaseHow pregnancy can affect autoimmune diseases progression?No quiet surrender: molecular guardians in multiple sclerosis brainMultiple Sclerosis and T Lymphocytes: An Entangled StoryInterferons at age 50: past, current and future impact on biomedicineExperimental allergic encephalomyelitis: a misleading model of multiple sclerosisExpression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosisThe functions of cytokines and their uses in toxicologyEndoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gammaExcessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosisT cells, cytokines, and autoantigens in multiple sclerosis.Interferon-gamma protects astrocytes from apoptosis and increases the formation of p21ras-GTP complex through ras oncogene family overexpression.Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis.[Interferon therapy and autoimmunity]Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanismsAutoimmune disease and the nervous system. Biochemical, molecular, and clinical update.Pregnancy in multiple sclerosisMolecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity.A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis.Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein.T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.Gammadelta T cells in EAE: early trafficking events and cytokine requirements.Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluidImportance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.The pathogenesis of murine coronavirus infection of the central nervous system.The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy.Therapeutic strategies in multiple sclerosis. I. ImmunotherapyThe innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis.Saccharin derivatives as inhibitors of interferon-mediated inflammation.New treatments for multiple sclerosis.
P2860
Q24603606-9E7F7491-F1A0-4D01-B53A-C8FA79B58613Q24672740-8A506F4B-9C44-41A7-9232-9202FF33E415Q24805642-A15FEC8C-F46F-4C85-A541-235B53DF80F3Q26781529-D50E9789-EDB5-4B6C-B2A3-5776238A3BD4Q26784619-4BBC1697-04B3-46E4-A466-FFD25737FFD8Q26797409-D39A45AE-CC53-4F41-8A6F-03A8596F7B27Q26826930-F3CFEB6A-66C8-4944-8C64-0993883C595AQ26863405-8B01C483-A507-482A-ABBF-6881A9FA591CQ27011014-54033444-863B-40CC-B8E3-34CC0388A24CQ27928023-D373CE0D-C7AB-4FF6-955D-E157467320F0Q28073898-C3EBEB7D-203A-4C14-B1D0-3D97233431A5Q28084633-C6A163F3-1D6C-4E76-9D54-731AF8D5475FQ28086853-91A03883-534C-475B-AF1B-38BE6B5284CCQ28259312-2E9ACEA2-A1D7-497E-A408-B8BF38C593A1Q28284231-4DC27051-FD01-4408-AFDF-E7C7330D6231Q28285576-AAC69C88-C2C0-4C63-AAA1-C4BB0AF5788EQ28385281-B833E67A-D132-41D7-8A73-5B19FD543F42Q28591592-C3FA9074-C605-45E9-9DCE-3A083CFB31E5Q28744592-7BF85676-85D3-4D6C-A845-3C899419240AQ30680147-0C295231-9A8E-40CF-A6E3-2A7DE1BEF44CQ31949267-2C2D56B8-163F-4BA8-A3E1-B3195B073D29Q32091509-9159A5B3-9A87-4F23-9F86-D6FDC30D5035Q33243924-F6BCC8D7-178B-42F3-8020-850D4C7AD080Q33499922-6B312AB4-454D-4A47-9F62-54D7A788B6C4Q33554801-4D00E5A5-EBEB-420D-8D22-B4282A67B0FBQ33560305-DBEA8524-C7FB-4D39-B31F-0AE79036D2E7Q33591852-5A2225DF-EAED-4F87-B187-D33CFF4F5AACQ33630981-467CBA50-667B-4051-8B5B-D19701F3C4A7Q33637353-659543ED-BDA2-4A8D-8A9C-30218A700DF3Q33713319-35A76359-711C-42B2-AF6D-1B3F3E9309EBQ33723154-0FC8E7FF-D1BB-4E9D-844B-128208AE193EQ33725068-1BEF65B6-22D0-4DB7-9C40-0C0A0F7E85D7Q33732430-06052A41-6849-4C36-A580-94C4BE21AB2EQ33740931-2FED5EAD-B961-4766-9FE5-5B71D30E6A5EQ33779927-DBB5CA82-F91D-43D8-841A-C5E0870E3FC1Q33784067-9CFA4DBD-920D-48BE-A01E-FE56821BA13DQ33798254-A6EBC3B7-CA92-47F2-A50F-FBCAD3968A3CQ33810082-02C4BE7E-78F6-49CB-A9DB-9823219342D0Q33837232-6A040B58-D0DA-4B9B-9F0E-5FF708A0D9E5Q33839120-F9B52375-4DAB-4E29-8C05-5F08F6FECE72
P2860
Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Treatment of multiple sclerosi ...... tivation of the immune system.
@en
type
label
Treatment of multiple sclerosi ...... tivation of the immune system.
@en
prefLabel
Treatment of multiple sclerosi ...... tivation of the immune system.
@en
P2093
P356
P1433
P1476
Treatment of multiple sclerosi ...... tivation of the immune system.
@en
P2093
Johnson KP
Panitch HS
Schindler J
P304
P356
10.1212/WNL.37.7.1097
P407
P577
1987-07-01T00:00:00Z